Bottom line
How much do LOGSX and RYHIX overlap?
39% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 48.3% of LOGSX's assets and 19.9% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
RYHIX holds far more positions (135 vs 28), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings LOGSX and RYHIX have in common
| Holding | % of LOGSX | % of RYHIX | Overlap |
|---|---|---|---|
| Cardinal Health Inc | 5.86% | 0.86% | 0.86% |
| Amgen Inc | 4.86% | 1.56% | 1.56% |
| Mckesson Corp | 4.53% | 1.05% | 1.05% |
| Regeneron Pharmaceuticals Inc | 4.43% | 0.90% | 0.90% |
| Bristol-myers Squibb Company | 4.02% | 1.22% | 1.22% |
| Johnson & Johnson | 3.77% | 2.88% | 2.88% |
| Gilead Sciences Inc | 3.50% | 1.39% | 1.39% |
| Cigna Group (the) | 3.46% | 0.94% | 0.94% |
| Vertex Pharmaceuticals Inc | 3.26% | 1.34% | 1.34% |
| Merck & Company Inc | 3.16% | 2.04% | 2.04% |
| Intuitive Surgical Inc | 2.99% | 1.31% | 1.31% |
| Novo Nordisk A/s | 2.51% | 0.83% | 0.83% |
| Eli Lilly & Company | 1.99% | 3.63% | 1.99% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in LOGSX
- N/a — 6.91%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Cencora Inc — 4.46%
- National Healthcare Corp — 3.87%
- Medpace Holdings Inc — 3.69%
- Incyte Corp — 3.30%
- Medtronic Plc — 3.01%
- Labcorp Holdings Inc — 2.29%
Only in RYHIX
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Thermo Fisher Scientific Inc — 1.61%
- Abbott Laboratories — 1.42%
- Cvs Health Corp — 1.31%
- Danaher Corp — 1.30%
- Pfizer Inc — 1.25%
- Stryker Corp — 1.21%
- Elevance Health Inc — 1.02%
- Hca Healthcare Inc — 0.87%
- Boston Scientific Corp — 0.86%
- Edwards Lifesciences Corp — 0.84%
Asset mix
| Asset type | LOGSX | RYHIX |
|---|---|---|
| Stocks | 97.2% | 83.2% |
| Repurchase agreements | 6.9% | 0.9% |
| Cash & short-term funds | 1.6% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | LOGSX | RYHIX |
|---|---|---|
| US | 89.7% | 73.0% |
| IE | 8.8% | 3.3% |
| CH | 4.7% | 2.3% |
| DK | 2.5% | 1.4% |
| GB | — | 1.8% |
| NL | — | 0.7% |
| IL | — | 0.6% |
| DE | — | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do LOGSX and RYHIX overlap?
What stocks do LOGSX and RYHIX have in common?
Should I own both LOGSX and RYHIX?
Which holds more stocks, LOGSX or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.